On August 27, the European Commission announced that Novartis CAR-T cell therapy Kymriah has been approved to treat pediatric and adult patients with relapsed/refractory acute lymphoblastic leukemia (ALL) and relapsed/refractory diffuse large B-cell lymphoma (DLBCL) in Europe.
On Saturday, July 21 we had the pleasure of attending the 27th Annual Glenn O. Hawbaker Charity Golf Tournament at Penn State Blue and White Courses in State College, Pa. The Emily Whitehead Foundation was invited to participate as one of eight beneficiaries of this year's tournament.
On Friday, July 13 we hosted our 4th annual "Tee Off for T-Cells" golf tournament at Philipsburg Elks Lodge and Country Club in our hometown of Philipsburg, Pa. This year's event was our most successful yet and raised over $66,000!